Skip to content
Screener

Reported August 4, 2026 · Before market open

Revenue$8.9MBeat by $837.5K
EPS-$1.22Miss by $0.16
Revenue estimate$8.0M
EPS estimate-$1.06

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$6.8M
EPS estimate-$1.18

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$3.64B+70.0%
Enterprise value$3.51B+71.0%
P/S15.7×

FAQ

When did IDEAYA Biosciences, Inc. report Q2 2026 earnings?
IDEAYA Biosciences, Inc. (IDYA) reported Q2 2026 earnings on August 4, 2026 before market open.
What were IDEAYA Biosciences, Inc.'s Q2 2026 revenue and EPS?
IDEAYA Biosciences, Inc. reported revenue of $8.9M and eps of $-1.22 for Q2 2026.
Did IDEAYA Biosciences, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $8.0M by $837.5K. EPS missed the consensus estimate of $-1.06 by $0.16.
How did IDEAYA Biosciences, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 38.6% from $-0.88.
Where can I find IDEAYA Biosciences, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-331381) and the 10-Q periodic report (0001193125-26-332774) directly on SEC EDGAR. The filing index links above go to sec.gov.